Filtering





DOP29: The Normalization and Transition of J-Pouch Phenotype in the Chicago Classification of PouchitisECCO'21 Virtual
Year: 2021
Authors: Akiyama, S.(1);Cohen, N.(1);Traboulsi, C.(1);Rai, V.(1);Glick, L.(1);Yi, Y.(1);Runde, J.(1);Cohen, R.(1);Skowron, K.(1);Hurst, R.(1);Umanskiy, K.(1);Shogan, B.(1);Hyman, N.(1);Rubin, M.(1);Dalal, S.(1);Sakuraba, A.(1);Pekow, J.(1);Chang, E.(1);Ollech, J.(1);Rubin, D.(1)
(1)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States
DOP30: Segmental vs extended colectomy for colorectal cancer in Crohn’s Disease: Results from a multi-centre retrospective comparative studyECCO'21 Virtual
Year: 2021
Authors: Sensi, B.(1);Khan, J.(2);Janindra, W.(3);siragusa, L.(1);panis, Y.(4);frontali, A.(4);Stefan, S.(5);Bellato, V.(6);Espin Basany, E.(7);Marti-Gallostra, M.(7);Frasson, M.(8);Garcia Granero, E.(9);spinelli, A.(10);carvello, M.(10);Sampietro, G.(11);fichera, A.(12);Artigue, M.(12);Zaghiyan, K.(13);Adams, E.(14);Konishi, T.(15);pellino, G.(16);Sica, G.(1)
(1)University of Rome Tor Vergata, Department of Surgery, Rome, Italy;(2)portsmouth hospital nhs trust, surgery, portsmouth, United Kingdom;(3)saint mark's, surgery, london, United Kingdom;(4)beaujon hospital, colorectal surgery, paris, France;(5)portsmouth hospitals nhs trust, surgery, portsmouth, United Kingdom;(6)saint mark's hospital, surgery, london, United Kingdom;(7)hospital universitario val d'hebron, surgery, barcelona, Spain;(8)Hospital universitario La Fe, surgery, valencia, Spain;(9)Hospital universitario La Fe, surgery, vlencia, Spain;(10)istituto clinico humanitas, surgery, rozzano, Italy;(11)Rho memorian hospital, surgery, milan, Italy;(12)baylor university medical center, surgery, dallas, United States;(13)cedars sinai hospital, surgery, Los Angelese, United States;(14)cedars sinai hospital, surgery, Los Angeles, United States;(15)md anderson center, surgery, houston, United States;(16)università federico II, surgery, Napoli, Italy
DOP31: Management and outcome of postoperative Crohn’s Disease in the elderly as compared to young adults: Data from Eneida registryECCO'21 Virtual
Year: 2021
Authors: Mañosa Ciria, M.(1,2);Calafat, M.(1,2);Ricart, E.(2,3);Nos, P.(2,4);Iglesias, E.(5);Riestra, S.(6);López-Sanroman, A.(7);Vera, M.(8);Guardiola, J.(9);Hernández, V.(10);Rivero, M.(11);Carpio, D.(12);Mínguez, M.(13);Alba, C.(14);Martín-Arranz, M.D.(15);Rodríguez, E.(16);Gomollon, F.(17);Garcia-López, S.(18);Gutiérrez Casbas, A.(2,19,20);Calvet, X.(2,21);González-Muñoza, C.(22);Barrio, J.(23);P Gisbert, J.(2,24);Sicilia, B.(25);Pérez-Calle, J.L.(26);Bujanda, L.(2,27);Esteve, M.(2,28);Ramos, L.(29);Varela, P.(30);Sierra, M.(31);Merino, O.(32);Bermejo, F.(33,34);Barreiro-de Acosta, M.(35);Rodríguez, A.(36);Márquez, L.(37);Garcia-Bosch, O.(38);Cabriada, J.L.(39);Lorente, R.(40);Cañete, F.(1,2);Domènech, E.(1,2)
(1)Hospital Universitari Germans Trias I Pujol, Gastroenterology, Badalona, Spain;(2)CiberHED, CiberHED, Madrid, Spain;(3)Hospital Clinic, Gastroenterology, Barcelona, Spain;(4)Hospital La Fe, Gastroenterology, Valencia, Spain;(5)Hospital Reina Sofia, Gastroenterology, Córdoba, Spain;(6)Hospital Central de Asturias, Gastroenterologia, Oviedo, Spain;(7)Hospital Ramon y Cajal, Gastroenterology, Madrid, Spain;(8)Hospital Puerta de Hierro, Gastroenterology, Majadahonda, Spain;(9)Hospital de Bellvitge, Gastroenterology, Hospitalet de LLobregat, Spain;(10)Hospital Álvaro Cunqueiro, Gastroenterology, Vigo, Spain;(11)Hospital Marques de Valdecillas, Gastroenterology, Santander, Spain;(12)Complexo Hospitalario Universitario de Pontevedra, Gastroenterology, Pontevedra, Spain;(13)Hospital Clinic Universitario, Gastroenterology, Valencia, Spain;(14)Hospital Clínico San Carlos, Gastroenterology, Madrid, Spain;(15)Hospital Universitario La Paz, Gastroenterology, Madrid, Spain;(16)Hospital Nuestra Señora de la Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain;(17)Hospital Universitario Lozano Blesa, Gastroenterology, Zaragoza, Spain;(18)Hospital Universitario Miguel Servet, Gastroenterology, Zaragoza, Spain;(19)Hospital General Universitario de Alicante, Gastroenterology, Alicante, Spain;(20)Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL, IsaBIAL, Alicante, Spain;(21)Hospital Parc taulí, Gastroenterology, Sabadell, Spain;(22)Hospital de la Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain;(23)Hospital Universitario Río Hortega, Gastroenterology, Valladolid, Spain;(24)Hospital la Princesa, Gastroenterology, Madrid, Spain;(25)Hospital Universitario Burgos, Gastroenterology, Burgos, Spain;(26)Hospital Fundación Alcorcón, Gastroenterology, Alcorcón, Spain;(27)Hospital Universitario de Donostia, Gastroenterology, Donostia, Spain;(28)Hospital Universitari Mútua de Terrassa, Gastroenterology, Terrassa, Spain;(29)Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain;(30)Hospital Universitario de Cabueñes, Gastroenterology, Gijón, Spain;(31)Hospital Universitario de León, Hospital Universitario de León, León, Spain;(32)Hospital Universitario de Cruces, Gastroenterology, Barakaldo, Spain;(33)Hospital Universitario de Fuenlabrada, Gastroenterology, Fuenlabrada, Spain;(34)Instituto Hospital Universitario La Paz IdiPAZ, IdiPAZ, Madrid, Spain;(35)Hospital Clínico Universitario de Santiago, Gastroenterology, Santiago de Compostela, Spain;(36)Hospital Universitario de Salamanca, Gastroenterology, Salamanca, Spain;(37)Hospital del Mar, Gastroenterology, Barcelona, Spain;(38)Hospital Moisès Broggi, Gastroenterology, Sant Joan Despí, Spain;(39)Hospital de Galdakao, Gastroenterology, Bilbao, Spain;(40)Hospital general de Ciudad Real, Gastroenterology, Ciudad Real, Spain; ENEIDA
DOP32: Long-term outcomes of enterocutaneous fistula complicating Crohn’s Disease: The ECUFIT study from GETECCUECCO'21 Virtual
Year: 2021
Authors: Rodríguez-Lago, I.(1);García Pérez, C.(2);Calafat, M.(3);Soto, M.P.(4);Calvo, M.(5);Sánchez Rodríguez, E.(6);Caballol, B.(7);Vela, M.(8);Rivero, M.(9);Muñoz, F.(10);De Castro, L.(11);Calvet, X.(12);García-Alonso, F.J.(13);Utrilla Fornals, A.(14);Ferreiro-Iglesias, R.(15);González-Muñoza, C.(16);Chaparro, M.(17);Luis, B.(18);Sicilia, B.(19);Alfambra, E.(20);Rodriguez, A.(21);Pérez Fernández, R.(22);Rodríguez, C.(23);Almela, P.(24);Argüelles, F.(25);Busquets, D.(26);Tamarit-Sebastián, S.(27);Reygosa Castro, C.(28);Jiménez, L.(29);Marín-Jiménez, I.(30);Alcaide, N.(31);Fernández-Salgado, E.(32);Iglesias Gómez, Á.(33);Ponferrada, Á.(34);Pajares, R.(35);Roncero, Ó.(36);Morales-Alvarado, V.J.(37);Cabriada, J.L.(1);Domènech, E.(3);Barreiro-de Acosta, M.(15)
(1)Hospital de Galdakao- Biocruces Bizkaia Health Research Institute, Gastroenterology, Galdakao, Spain;(2)Hospital Universitario Central de Asturias- Instituto de Investigación Sanitaria del Principado de Asturias, Gastroenterology, Oviedo, Spain;(3)Hospital Universitari German Trias i Pujol, Gastroenterology, Badalona, Spain;(4)Hospital Universitario Reina Sofía, Gastroenterology, Córdoba, Spain;(5)Hospital Universitario Puerta de Hierro, Gastroenterology, Mahadahonda, Spain;(6)Hospital Universitario Ramón y Cajal, Gastroenterology, Madrid, Spain;(7)Hospital Clinic, Gastroenterology, Barcelona, Spain;(8)Hospital Universitario Nuestra Señora de Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain;(9)Hospital Universitario Marqués de Valdecilla, Gastroenterology, Santander, Spain;(10)Hospital Universitario de Salamanca, Gastroenterology, Salamanca, Spain;(11)Hospital Álvaro Cunqueiro, Gastroenterology, Vigo, Spain;(12)Corporació Parc Taulí, Gastroenterology, Sabadell, Spain;(13)Hospital Universitario Río Hortega, Gastroenterology, Valladolid, Spain;(14)Hospital General San Jorge, Gastroenterology, Huesca, Spain;(15)Hospital Clínico Universitario de Santiago, Gastroenterology, Santiago de Compostela, Spain;(16)Hospital Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain;(17)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Madrid, Spain;(18)Hospital Universitario Donostia, Gastroenterology, Donostia, Spain;(19)Hospital Universitario de Burgos, Gastroenterology, Burgos, Spain;(20)Hospital Clínico Universitario Lozano Blesa, Gastroenterology, Zaragoza, Spain;(21)Hospital General Universitario de Alicante, Gastroenterology, Alicante, Spain;(22)Complejo Asistencial Universitario de León, Gastroenterology, León, Spain;(23)Complejo Hospitalario de Navarra, Gastroenterology, Pamplona, Spain;(24)Hospital General Universitari de Castelló, Gastroenterology, Castelló, Spain;(25)Hospital Universitario Virgen Macarena, Gastroenterology, Sevilla, Spain;(26)Hospital Universitari Girona Dr. Josep Trueta, Gastroenterology, Girona, Spain;(27)Hospital General de Tomelloso, Gastroenterology, Tomelloso, Spain;(28)Complejo Hospitalario Universitario de Canarias, Gastroenterology, San Cristóbal de La Laguna, Spain;(29)Hospital Universitario de Fuenlabrada, Gastroenterology, Fuenlabrada, Spain;(30)Hospital General Universitario Gregorio Marañón, Gastroenterology, Madrid, Spain;(31)Hospital Clínico Universitario de Valladolid, Gastroenterology, Valladolid, Spain;(32)Complejo Hospitalario Universitario de Pontevedra, Gastroenterology, Pontevedra, Spain;(33)Complexo Hospitalario Universitario de Ourense, Gastroenterology, Ourense, Spain;(34)Hospital Universitario Infanta Leonor, Gastroenterology, Madrid, Spain;(35)Hospital Universitario Infanta Sofía, Gastroenterology, San Sebastián de los Reyes, Spain;(36)Hospital General La Mancha Centro, Gastroenterology, Alcázar de San Juan, Spain;(37)Hospital General de Granollers, Gastroenterology, Granollers, Spain; on behalf of the ECUFIT study group from the ENEIDA registry
DOP33: Predictors of ileo-rectal anastomosis, permanent ileostomy and recurrence of disease after total colectomy for Crohn’s Colitis: Results over 20 yearsECCO'21 Virtual
Year: 2021
Authors: Rottoli, M.(1);Melina, M.(1);Tanzanu, M.(1);Romano, A.(1);Belvedere, A.(1);Parlanti, D.(1);Pezzuto, A.P.(1);Salice, M.(2);Rizzello, F.(2);Gionchetti, P.(2);Poggioli, G.(1)
(1)Alma Mater Studiorum University of Bologna. IRCCS Azienda Ospedaliero-Universitaria di Bologna., Surgery of the Alimentary Tract. Department of Medical and Surgical Sciences, Bologna, Italy;(2)Alma Mater Studiorum University of Bologna. IRCCS Azienda Ospedaliero-Universitaria di Bologna., IBD Unit. Department of Medical and Surgical Sciences, Bologna, Italy
DOP34: Long-term outcome of Acute Severe Ulcerative Colitis responsive to intravenous steroid: A multicenter study of the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)ECCO'21 Virtual
Year: 2021
Authors: Festa, S.(1);Scribano, M.L.(2);Aratari, A.(1);Bezzio, C.(3);Principi, M.(4);Pugliese, D.(5);Ribaldone, D.G.(6);Furfaro, F.(7);Mocci, G.(8);Spagnuolo, R.(9);Vernia, P.(10);Costa, F.(11);Cosintino , R.(2);De Biasio, F.(1);Saibeni, S.(3);Armuzzi, A.(5);Papi, C.(1)
(1)San Filippo Neri Hospital, IBD Unit, Rome, Italy;(2)AO San Camillo Forlanini, Gastroenterology Unit, Rome, Italy;(3)Rho Hospital- ASST Rhodense, Gastroenterology Unit, Rho Milan, Italy;(4)AOU Policlinico di Bari, Emergency and Organ Transplantation Department- Section of Gastroenterology, Bari, Italy;(5)Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, CEMAD – IBD UNIT - Unità Operativa Complessa di Medicina Interna e Gastroenterologia- Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italy;(6)University of Turin-, Department of Medical Sciences, Turin, Italy;(7)Humanitas University, IBD Centre- Humanitas Clinical and Research Centre- Department of Biomedical Sciences, Rozzano Milan, Italy;(8)Brotzu Hospital, Gastroenterology Unit- Department of Medicine, Cagliari, Italy;(9)AOU Mater Domini- University Magna Graecia, Gastroenterology Unit, Catanzaro, Italy;(10)Department of Translational and Precision Medicine- Sapienza University of Rome, Division of Gastroenterology, Rome, Italy;(11)Department of General Surgery- AOUP, IBD unit, Pisa, Italy
DOP35: Ambulatory care management of 70 patients with Acute Severe Ulcerative Colitis in comparison to 700 inpatients: Insights from a multicentre UK cohort studyECCO'21 Virtual
Year: 2021
Authors: Patel, K.V.(1);Segal, J.(2);Sebastian, S.(3,4);Subramanian, S.(5,6);Conley, T.(5);Gonzalez, H.(3,4);Kent, A.(7);Saifuddin, A.(7);Hicks, L.(2);Mehta, S.(8);Bhala, N.(9,10);Brookes, M.(11,12);Lamb, C.(13,14);Kennedy, N.(15,16);Walker, G.(17)
(1)St George’s University Hospitals NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom;(2)Imperial College London, Department of Gastroenterology, London, United Kingdom;(3)Hull University Teaching Hospitals NHS Trust, Department of Gastroenterology, Hull, United Kingdom;(4)University of Hull, Faculty of Health Sciences, Hull, United Kingdom;(5)Liverpool University Hospitals NHS Trust, Department of Gastroenterology, Liverpool, United Kingdom;(6)University of Liverpool, Department of Gastroenterology, Liverpool, United Kingdom;(7)King’s College Hospital NHS Foundation, Department of Gastroenterology, London, United Kingdom;(8)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)Queen Elizabeth Hospital Birmingham NHS Foundation, Department of Gastroenterology, Birmingham, United Kingdom;(10)University of Birmingham, Medicine, Birmingham, United Kingdom;(11)Royal Wolverhampton NHS Trust, Department of Gastroenterology, Wolverhampton, United Kingdom;(12)University of Wolverhampton, Research Institute in Healthcare Science, Wolverhampton, United Kingdom;(13)Newcastle upon Tyne Hospitals NHS Foundation Trust, Department of Gastroenterology, Newcastle, United Kingdom;(14)Newcastle University, Department of Gastroenterology, Newcastle, United Kingdom;(15)Royal Devon and Exeter NHS Foundation Trust, Department of Gastroenterology, Exeter, United Kingdom;(16)University of Exeter, Department of Gastroenterology, Exeter, United Kingdom;(17)Torbay and South Devon NHS Foundation Trust, Department of Gastroenterology, Torbay, United Kingdom; PROTECT ASUC collaborators
DOP36: Non-invasive assessment of postoperative disease recurrence in Crohn’s Disease: A multicenter, prospective cohort studyECCO'21 Virtual
Year: 2021
Authors: Furfaro, F.(1);Zilli , A.(1);Craviotto, V.(1);Aratari , A.(2);Bezzio, C.(3);Gilardi, D.(1);D'Amico, F.(1);Saibeni, S.(3);Papi, C.(2);Peyrin-Biroulet, L.(4);Fiorino, G.(5);Danese, S.(5);Allocca, M.(5)
(1)Humanitas Clinical and Research Center – IRCCS, IBD Unit, Rozzano, Italy;(2)San Filippo Neri Hospital, IBD Unit, Rome, Italy;(3)Rho Hospital- ASST Rhodense- Garbagnate Milanese, Gastroenterology Unit, Milano, Italy;(4)University Hospital of Nancy- Université de Lorraine, Department of Gastroenterology, Nancy, France;(5)Humanitas University- Pieve Emanuele, Department of Biomedical Sciences, Milan, Italy; IG-IBD
DOP37: Large differences in IBD care and education across Europe, first results of the pan-European VIPER surveyECCO'21 Virtual
Year: 2021
Authors: Král, J.(1);Nakov, R.(2);Lanska, V.(3);Barberio, B.(4);Benech, N.(5);Blesl, A.(6);Brunet, E.(7);Capela, T.L.(8);Derikx, L.A.A.P.(9);Dragoni, G.(10);Eek, A.(11);Frias-Gomes , C.(12);Gîlcă-Blanariu , G.E.(13);Gilroy, L.(14);Harvey, P.R.(15);Kagramanova, A.(16);Kani, H.T.(17);Konikoff, T.(18);Lessing, M.(19);Madsen, G.R.(20);Maksimaityte, V.(21);Miasnikova, M.(22);Mikolasevic, I.(23);Milivojevic, V.(24);Noviello, D.(25);Oliinyk, D.(26);Patai, A.(27);Protopapas, A.A.(28);Rodríguez-Lago, I.(29);Schreiber, P.(30);Skuja, V.(31);Tran, F.(19);Truyens, M.(32);Włodarczyk, M.(33);Zatorski, H.(34);Verstockt, B.(35);Segal, J.P.(36)
(1)Institute for Clinical and Experimental Medicine, Department of Hepatogastroenterology, Prague, Czech Republic;(2)Tsaritsa Yoanna University Hospital- Medical University of Sofia, Department of Gastroenterology, Sofia, Bulgaria;(3)Institute for Clinical and Experimental Medicine, IT Department, Prague, Czech Republic;(4)Gastroenterology Unit- University of Padova-Azienda Ospedaliera di Padova, Department of Surgery- Oncology and Gastroenterology DISCOG, Padova, Italy;(5)Saint Antoine Hospital- AP-HP, Department of Gastroenterology, Paris, France;(6)Medical University of Graz, Department of Internal Medicine- Division of Gastroenterology and Hepatology, Graz, Austria;(7)Hospital Parc Tauli, Department of Gastroenterology, Sabadell, Spain;(8)Hospital Senhora da Oliveira, Gastroenterology Department, Guimarães, Portugal;(9)Inflammatory Bowel Disease Center- Radboud University Medical Center, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(10)IBD Referral Center- Careggi University Hospital, Department of Gastroenterology, Florence, Italy;(11)Tartu University hospital, Department of Gastroenterology, Tartu, Estonia;(12)Hospital Beatriz Ângelo, Gastroenterology division- Surgery department, Loures, Portugal;(13)Grigore T Popa University of Medicine and Pharmacy, Gastroenterology Department, Lași, Romania;(14)Royal Victoria Hospital, Department of Gastroenterology, Belfast, United Kingdom;(15)Harvey PR- Russells Hall Hospital, Department of Gastroenterology, Dudley, United Kingdom;(16)Moscow Clinical Scientific Centre n.a. A.S. Loginov, IBD department, Moscow, Russian Federation;(17)Marmara University- School of Medicine, Department of Gastroenterology, Istanbul, Turkey;(18)Rabin Medical Center- Sackler Faculty of Medicine, Division of Gastroenterology, Tel-Aviv, Israel;(19)University Medical Center Schleswig-Holstein, Department of Internal Medicine I, Kiel, Germany;(20)Copenhagen University Hospital Hvidovre, Gastrounit, Copenhagen, Denmark;(21)Institute of Clinical Medicine- Faculty of Medicine- Vilnius University, Clinic of Gastroenterology- Nephrology- and Surgery, Vilnius, Lithuania;(22)Medical Center Medeor, Out-patient department, Chelyabinsk, Russian Federation;(23)UHC Rijeka and UH Merkur, Department of Gastroenterology, Rijeka, Croatia;(24)Clinical center of Serbia- School of medicine, Clinic for gastroenterology and hepatology, Belgrade, Serbia;(25)University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy;(26)Bogomolets National Medical University, Department of surgery №1, Kyiv, Ukraine;(27)Semmelweis University, Department of Internal Medicine and Hematology, Budapest, Hungary;(28)Aristotle University of Thessaloniki- AHEPA Hospital, First Propedeutic Department of Internal Medicine, Thessaloniki, Greece;(29)Hospital de Galdakao, Department of Gastroenterology, Galdakao, Spain;(30)University Hospital Zurich, Department of Gastroenterology & Hepatology, Zurich, Switzerland;(31)Riga Stradins University, Gastroenterology- Hepatology and Nutrition Clinic, Riga, Latvia;(32)Ghent University, Department of Internal Medicine and Pediatrics, Ghent, Belgium;(33)Faculty of Medicine- Medical University of Lodz, Department of General and Colorectal Surgery- Department of Biochemistry, Lodz, Poland;(34)Faculty of Medicine- Medical University of Lodz, Department of Digestive Tract Diseases, Lodz, Poland;(35)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(36)Hillingdon Hospital, Department of Gastroenterology, Uxbridge, United Kingdom
DOP38: An observational study to evaluate the burden of illness in patients with Crohn’s Disease with and without perianal fistulas in the USAECCO'21 Virtual
Year: 2021
Authors: Jiang, J.(1);Cazzetta, S.E.(2);Athavale, A.(3);Kuharic, M.(1,4);Fan, T.(1);Silber, A.(5);Vijay, A.(3);Hadker, N.(5);Sharpe, E.(5);Nazarey, P.P.(2)
(1)Takeda Pharmaceuticals USA- Inc., Health Economics and Outcomes Research, Lexington, United States;(2)Takeda Pharmaceuticals USA- Inc., Medical Affairs, Lexington, United States;(3)Trinity Partners- LLC, Quantitative Research, Waltham, United States;(4)University of Illinois, Department of Pharmacy Systems- Outcomes and Policy- College of Pharmacy, Chicago, United States;(5)Trinity Partners- LLC, Health Economics and Outcomes Research, Waltham, United States
DOP39: Utilization and sustainability of biologics in UC - A nationwide study from the epi-IIRNECCO'21 Virtual
Year: 2021
Authors: Atia, O.(1); Yogev, D.(1); Friss, C.(1); Focht, G.(1); Orlanski-Meyer, E.(1); Magen Rimon, R.(2); Ledderman, N.(3); Greenfeld, S.(4); Kariv, R.(5); Loewenberg Weisband, Y.(6); Gabay, H.(6); Nevo, D.(7); Matz, E.(8); Gorelik, Y.(9); Chowers, Y.(9); Dotan, I.(10);Turner, D.(1)
(1)Shaare Zedek Medical Center- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Pediatric Gastroenterology & Nutrition institute- Ruth Rappaport Children's Hospital, Rambam Medical Center- Faculty of Medicine- Technion, Haifa, Israel;(3)Meuhedet Health Services, Meuhedet Health Services, Tel-Aviv, Israel;(4)Maccabi Health Services, The Sackler Faculty of Medicine- Tel Aviv University, Tel-Aviv, Israel;(5)Maccabi Health Services, The Sackler Faculty of Medicine- Tel Aviv University- Israel., Tel-Aviv, Israel;(6)Clalit Health Services, Clalit Research Institute, Tel-Aviv, Israel;(7)Department of Statistics and Operations Research, Tel Aviv University- Israel, Tel Aviv, Israel;(8)Leumit Health Services, Leumit Health Services, Tel-Aviv, Israel;(9)Technion Israel Institute of Technology- Department of Gastroenterology, Rambam Healthcare Campus- Bruce Rappaport School of Medicine, Haifa, Israel;(10)Division of Gastroenterology- Rabin Medical Center, The Sackler Faculty of Medicine- Tel Aviv University- Israel., Petah Tikva, Israel
DOP40: Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control studyECCO'21 Virtual
Year: 2021
Authors: Zabana Abdo, Y.(1,2);Marín-Jiménez, I.(3);Rodríguez-Lago, I.(4);Vera, I.(5);Martín, M.D.(6);Guerra, I.(7);Gisbert, J.P.(2,8);Mesonero, F.(9);Benítez, O.(1);Taxonera, C.(10);Ponferrada-Díaz, Á.(11);Piqueras, M.(12);Lucendo, A.(2,13);Caballol, B.(2,14);Mañosa, M.(2,15);Martínez-Montiel, P.(16);Bosca-Watts, M.(17);Gordillo, J.(18);Bujanda, L.(19);Manceñido, N.(20);Martínez-Pérez, T.(21);López, A.(22);Rodríguez, C.(23);García-López, S.(24);Vega, P.(25);Rivero, M.(26);Melcarne, L.(27);Calvo, M.(28);Iborra, M.(2,29);Barreiro-de Acosta, M.(30);Arias, L.(31);Barrio, J.(32);Pérez, J.L.(33);Busquets, D.(34);Pérez-Martínez, I.(35);Navarro-Llavat, M.(36);Hernández, V.(37);Argüelles-Arias, F.(38);Domènech, E.(2,15);Esteve, M.(1,2)
(1)Hospital Universitari Mútua de Terrassa, Gastroenterology Department- Inflammatory Bowel Disease Unit, Terrassa, Spain;(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, CIBERehd, Madrid, Spain;(3)Hospital Gregorio Marañón, Gastroenterology Department, Madrid, Spain;(4)Hospital de Galdakao, Gastroenterology Department, Bilbao, Spain;(5)Hospital Universitario Puerta de Hierro Majadahonda, Gastroenterology Department, Majadahonda, Spain;(6)Hospital Universitario La Paz, Gastroenterology Department, Madrid, Spain;(7)Hospital Universitario de Fuenlabrada and Instituto de Investigación Hospital Universitario La Paz IdiPaz, Gastroenterology Department, Madrid, Spain;(8)Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa IIS-IP, Gastroenterology Department, Madrid, Spain;(9)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(10)Hospital Clínico San Carlos- Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Gastroenterology Department, Madrid, Spain;(11)Hospital Universitario Infanta Leonor, Gastroenterology Department, Madrid, Spain;(12)Consorci Sanitari de Terrassa, Gastroenterology Department, Terrassa, Spain;(13)Hospital General de Tomelloso and Instituto de Investigación Sanitaria Princesa IIS-IP, Gastroenterology Department, Tomelloso, Spain;(14)Hospital Clínic de Barcelona, Gastroenterology Department, Barcelona, Spain;(15)Hospital Universitari Germans Trias i Pujol, Gastroenterology Department, Badalona, Spain;(16)Fundación Hospital Universitario Doce de Octubre Madrid, Gastroenterology Department, Madrid, Spain;(17)Hospital Clinic Universitari de Valencia, Gastroenterology Department, Valencia, Spain;(18)Hospital de la Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(19)Hospital Universitario Donostia and Instituto Biodonostia- Universidad del País Vasco UPV/EHU, Gastroenterology Department, Donostia, Spain;(20)Hospital Universitario Infanta Sofía, Gastroenterology Department, San Sebastián de los Reyes, Spain;(21)Hospital Virgen de la Luz, Gastroenterology Department, Cuenca, Spain;(22)Hospital del Mar and Institut Hospital del Mar d’Investigacions Mèdiques IMIM Barcelona, Gastroenterology Department, Barcelona, Spain;(23)Complejo Hospitalario de Navarra, Gastroenterology Department, Navarra, Spain;(24)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(25)Complexo Hospitalario Universitario de Ourense, Gastroenterology Department, Ourense, Spain;(26)Hospital Universitario Marques de Valdecilla IDIVAL, Gastroenterology Department, Santander, Spain;(27)Hospital Universitari Parc Taulí, Gastroenterology Department, Sabadell, Spain;(28)Hospital San Pedro, Gastroenterology Department, Logroño, Spain;(29)Hospital Universitario y Politécnico de la Fe de Valencia, Gastroenterology Department, Valencia, Spain;(30)Hospital Universitario de Santiago 'CHUS', Gastroenterology Department, Santiago de Compostela, Spain;(31)Hospital Universitario de Burgos, Gastroenterolgy Department, Burgos, Spain;(32)Hospital Universitario Río Hortega HURH, Gastroenterology Department, Valladolid, Spain;(33)Hospital Universitario Fundación de Alcorcón, Gastroenterology Department, Alcorcón, Spain;(34)Hospital Universitari de Girona Doctor Josep Trueta, Gastroenterology Department, Girona, Spain;(35)Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Gastroenterology Department, Oviedo, Spain;(36)Hospital de Sant Joan Despí Moises Broggi, Gastroenterology Department, Sant Joan Despí, Spain;(37)Hospital Álvaro Cunqueiro Vigo, Gastroenterology Department, Vigo, Spain;(38)Hospital Universitario Virgen de la Macarena- Universidad de Sevilla, Gastroenterology Department, Sevilla, Spain; COVID-19-EII Consortium of the ENEIDA project of GETECCU
DOP41: Temporal Trends in the epidemiology of Inflammatory Bowel Diseases in the public healthcare system in Brazil: A large population-based studyECCO'21 Virtual
Year: 2021
Authors: Quaresma, A.B.(1);Damiao, A.O.M.C.(2);Coy, C.S.R.(3);Magro, D.O.(3);Valverde, D.A.(4);Panaccione, R.(5);Coward, S.B.(6);Ng, S.C.(7);Kaplan, G.G.(6);Kotze, P.G.(8)
(1)Universidade do Oeste Catarinense UNOESC, Colorectal Surgery, Joaçaba, Brazil;(2)University of Sao Paulo, Gastroenterology, Sao Paulo, Brazil;(3)University of Campinas UNICAMP, Colorectal Surgery Unit, Campinas, Brazil;(4)Techtrials Healthcare, Data Science, Vinhedo, Brazil;(5)University of Calgary, Division of Gastroenterology and Hepatology, Calgary, Canada;(6)University of Calgary, Department of Medicine and Community Health Sciences, Calgary, Canada;(7)Chinese University of Hong Kong, Department of Gastroenterology, Hong Kong, Hong Kong- China;(8)Catholic University or Paraná, IBD outpatient Clinics- Colorectal Surgery Unit, Curitiba, Brazil
DOP42: Disease course and clinical outcomes in Taiwan Crohn’s Disease patients with perianal fistula: A nationwide-based studyECCO'21 Virtual
Year: 2021
Authors: Weng, M.T.(1);Lin, K.L.(2);Chan, K.A.(3);Wei, S.C.(4)
(1)National Taiwan University Hospital, Department of Internal Medicine, Taipei, Taiwan- Province Of China;(2)National Taiwan University, Health Data Research Center, Taipei, Taiwan- Province Of China;(3)National Taiwan University, Health Data Research Center, Taipeit, Taiwan- Province Of China;(4)National Taiwan University Hospital, Departments of Internal Medicine, Taipei, Taiwan- Province Of China
DOP43: Impact of Inflammatory Bowel Diseases on the phenotype and severity of psoriasis and spondyloarthropathiesECCO'21 Virtual
Year: 2021
Authors: Attauabi, M.(1,2,3);Damsgaard Wewer, M.(1,3);Bendtsen, F.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3)
(1)Copenhagen University Hospital, Gastrounit- Medical Section, Hvidovre, Denmark;(2)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;(3)University of Copenhagen- Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark
DOP44: Long term outcomes of patients with untreated IBD - A population-based analysis from the epi-IIRNECCO'21 Virtual
Year: 2021
Authors: Magen Rimon, R.(1);Atia, O.(2);Friss, C.(2);Ledderman, N.(3);Greenfeld, S.(4);Kariv, R.(4);Loewenberg Weisband, Y.(5);Gabay, C.(5);Shaoul, R.(1);Odes, S.(6);Matz, E.(7);Dotan, I.(8);Turner, D.(2)
(1)Rambam Medical Center, Pediatric Gastroenterology & Nutrition institute, Haifa, Israel;(2)Shaare Zedek Medical Center, Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(3)Meuhedet Health Services, Meuhedet Health Services, Tel Aviv, Israel;(4)Maccabi Health Services, Maccabi Health Services, Tel Aviv, Israel;(5)Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel;(6)Ben-Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel;(7)Leumit Health Services, Leumit Health Services, Tel Aviv, Israel;(8)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel
DOP45: Utilization and sustainability of biologics in CD - A nationwide study from the epi-IIRNECCO'21 Virtual
Year: 2021
Authors: Atia, O.(1); Yogev, D.(1);Chagit, F.(1);Gili, F.(1); Orlanski-Meyer, E.(1);Magen Rimon, R.(2);Natan, L.(3);Shira, G.(4); Kariv, R.(4);Yisca, L.W.(5); Gabay, H.(5); Nevo, D.(6); Matz, E.(7); Gorelik, Y.(8); Chowers, Y.(8);Iris, D.(9);Turner, D.(1)
(1)Shaare Zedek Medical Center- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Pediatric Gastroenterology & Nutrition institute- Ruth Rappaport Children's Hospital- Rambam Medical Center, Faculty of Medicine- Technion, Haifa, Israel;(3)Meuhedet Health Services, Meuhedet Health Services, Tel-Aviv, Israel;(4)Maccabi Health Services, The Sackler Faculty of Medicine- Tel Aviv University- Israel., Tel-Aviv, Israel;(5)Clalit Health Services, Clalit Research Institute, Tel-Aviv, Israel;(6)Department of Statistics and Operations Research, Tel Aviv University- Israel, Tel Aviv, Israel;(7)Leumit Health Services, Leumit Health Services, Tel-Aviv, Israel;(8)Technion Israel Institute of Technology- Department of Gastroenterology, Rambam Healthcare Campus- Bruce Rappaport School of Medicine, Haifa, Israel;(9)Division of Gastroenterology- Rabin Medical Center, The Sackler Faculty of Medicine- Tel Aviv University- Israel, Petah Tikva, Israel
DOP46: Sustainability rate of immunomodulators monotherapy in patients with Crohn's Diseases: A population-based analysis from the epi-IIRN cohortECCO'21 Virtual
Year: 2021
Authors: Atia, O.(1); Friss, C.(1);Mendelovici, A.(1); Shteyer, E.(1); Yogev, D.(1);Ledderman, N.(2); Greenfeld, S.(3); Kariv, R.(3); Loewenberg Weisband, Y.(4); Gabay, H.(4); Nevo, D.(5); Matz, E.(6); Dotan, I.(7);Turner, D.(1)
(1)Shaare Zedek Medical Center- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Meuhedet Health Services, Meuhedet Health Services, Tel-Aviv, Israel;(3)Maccabi Health Services-, he Sackler Faculty of Medicine- Tel Aviv University- Israel., Tel Aviv, Israel;(4)Clalit Health Services, Clalit Research Institute, Tel-Aviv, Israel;(5)Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel;(6)Leumit Health Services-, . Leumit Health Services, Tel-Aviv, Israel;(7)Division of Gastroenterology- Rabin Medical Center, the Sackler Faculty of Medicine- Tel Aviv University- Israel., Petah Tikva, Israel
DOP47: Real World Evidence on the effectiveness of ustekinumab in Crohn’s Disease: Induction phase results from the prospective, observational RUN-CD StudyECCO'21 Virtual
Year: 2021
Authors: Bokemeyer, B.(1);Plachta-Danielzik, S.(2);Di Giuseppe, R.(3);Mohl, W.(4);Teich, N.(5);Hoffstadt, M.(6);Schweitzer, A.(7);von der Ohe, M.(8);Gauss, A.(9);Atreya, R.(10);Krause, T.(11);Blumenstein, I.(12);Höchstödter, J.(2);Hartmann , P.(1);Schreiber, S.(13)
(1)Interdisciplinary Crohn Colitis Centre Minden, Crohn Colitis, Minden, Germany;(2)Kompetenznetz Darmerkrankungen e.V., Abteilung Studien, Kiel, Germany;(3)Kompetenznetz Darmerkrankungen e.V., Epidemiology and Biometry, Kiel, Germany;(4)Gastroenterology Practice, Innere Medizin- Gastroenterologie- Ärztliches Qualitätsmanagement, Saarbrücken, Germany;(5)Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselerkrankungen, Innere Medizin- Gastroenterologie- Hepatologie- Proktologie, Münster, Germany;(6)Gastroenterology Practice, Medizinisches Versorgungszentrum, Iserlohn, Germany;(7)Gastroenterologische Gemeinschaftspraxis, Innere Medizin- Gastroenterologie- Hepatologie- Proktologie, Münster, Germany;(8)Gastroenterologische Gemeinschaftspraxis Herne, Gastroenterologische, Herne, Germany;(9)University Hospital Heidelberg, Department of Gastroenterology and Hepatology, Heidelberg, Germany;(10)Universitätsklinikum Erlangen, Innere Medizin, Erlangen, Germany;(11)Gastroenterological practice, Gastroenterology, Kassel, Germany;(12)Goethe-Universität Frankfurt am Main, Innere Medizin- Gastroenterologie- Ernährungsmedizin, Frankfurt am Main, Germany;(13)Universitätsklinikum Schleswig-Holstein UKSH, Klinik für Innere Medizin I, Kiel, Germany
DOP48: Use of biologic therapies with different mechanisms of action (MOA) in the first-line (1L) treatment of Crohn’s Disease (CD) in the U.S.ECCO'21 Virtual
Year: 2021
Authors: Huang, Z.(1);Ba, Y.(1);Kamble, P.(1);Wang, S.(1)
(1)Takeda, Gastroenterology- Global Outcomes, Cambridge, United States